• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4607200)   Today's Articles (1617)   Subscriber (49374)
For: Maritati F, Corradetti V, Bini C, Provenzano M, Cuna V, Busutti M, Tondolo F, Zappulo F, Vischini G, Iacovella F, Abenavoli C, Borelli G, Demetri M, Fabbrizio B, Radi G, Ravaioli M, Mele C, La Manna G, Comai G. "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. Kidney Int Rep 2024;9:982-993. [PMID: 38765562 PMCID: PMC11101752 DOI: 10.1016/j.ekir.2024.01.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Accepted: 01/08/2024] [Indexed: 05/22/2024]  Open
Number Cited by Other Article(s)
1
Busutti M, Maritati F, Borelli G, Bini C, Corradetti V, Cuna V, Abenavoli C, Provenzano M, Ravaioli M, La Manna G, Comai G. Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience. J Nephrol 2024:10.1007/s40620-024-02005-7. [PMID: 39009796 DOI: 10.1007/s40620-024-02005-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Accepted: 06/17/2024] [Indexed: 07/17/2024]
2
Maritati F, La Manna G, Comai G. Response to Letter to the Editor From Ville S. et al. About: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. Kidney Int Rep 2024;9:1933-1934. [PMID: 38899194 PMCID: PMC11184233 DOI: 10.1016/j.ekir.2024.03.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Revised: 03/22/2024] [Accepted: 03/25/2024] [Indexed: 06/21/2024]  Open
3
Bouwmeester RN, Wetzels JF, van de Kar NC. Eculizumab in Posttransplant TMA: Unproven Benefit: A Response to Maritati et al.: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. Kidney Int Rep 2024;9:1929. [PMID: 38899173 PMCID: PMC11184289 DOI: 10.1016/j.ekir.2024.02.1442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 02/26/2024] [Indexed: 06/21/2024]  Open
4
Ville S, Drapeau L, Paraire J, Maanaoui M, Frimat M. Letter to the editor about: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. Kidney Int Rep 2024;9:1932. [PMID: 38899204 PMCID: PMC11184236 DOI: 10.1016/j.ekir.2024.02.1440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Accepted: 02/26/2024] [Indexed: 06/21/2024]  Open
5
Maritati F, La Manna G, Comai G. Response to Letter to the Editor From Bouwmeester RN et al.: "Eculizumab in Postransplant TMA: Unproven Benefit.". Kidney Int Rep 2024;9:1930-1931. [PMID: 38899217 PMCID: PMC11184294 DOI: 10.1016/j.ekir.2024.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2024] [Accepted: 04/01/2024] [Indexed: 06/21/2024]  Open
6
Maritati F, La Manna G, Comai G. Response to "A Caution Against the Use of C5B-9 Endothelial Assay to Support Eculizumab Therapy". Kidney Int Rep 2024;9:1538-1539. [PMID: 38707838 PMCID: PMC11068969 DOI: 10.1016/j.ekir.2024.02.1436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2024] [Accepted: 02/26/2024] [Indexed: 05/07/2024]  Open
7
Duineveld C, van de Kar NC, Wetzels JF. A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: "Eculizumab first" in the management of posttransplant thrombotic microangiopathy. Kidney Int Rep 2024;9:1538. [PMID: 38707808 PMCID: PMC11068936 DOI: 10.1016/j.ekir.2024.02.1434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Accepted: 02/12/2024] [Indexed: 05/07/2024]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA